Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.44
+0.02 (0.37%)
At close: Feb 27, 2026, 4:00 PM EST
5.52
+0.08 (1.47%)
After-hours: Feb 27, 2026, 7:30 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $256.95 million as of February 27, 2026. Its market cap has increased by 30.82% in one year.
Market Cap
256.95M
Enterprise Value
154.94M
1-Year Change
30.82%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $256.95M, a decrease of -52.27%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 256.01M | -10.86% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 272.17M |
| Minerva Neurosciences | 269.60M |
| C4 Therapeutics | 269.42M |
| OmniAb | 259.12M |
| Shattuck Labs | 255.65M |
| Coherus Oncology | 252.61M |
| Achieve Life Sciences | 251.80M |
| Sol-Gel Technologies | 248.35M |